PPHM : Summary for Peregrine Pharmaceuticals Inc. - Yahoo Finance

We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. Markets closed

Peregrine Pharmaceuticals, Inc. (PPHM)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.55 +0.11 (+24.07%)
At close: 4:00PM EST
People also watch
CTIC THLD GALE XOMA CYTR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close 0.44
Open 0.45
Bid 0.56 x 1000
Ask 0.57 x 10000
Day's Range 0.45 - 0.66
52 Week Range 0.28 - 1.12
Volume 26,872,423
Avg. Volume 2,690,970
Market Cap 141.43M
Beta 2.09
PE Ratio (TTM) -2.17
EPS (TTM) -0.25
Earnings Date Mar 7, 2017 - Mar 13, 2017
Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 1.25
Trade prices are not sourced from all markets
  • Investopedia 9 days ago

    Peregrine Cancer Test Clears Proof of Concept

    Peregrine’s exosome-based cancer detection technology reported concrete results in early studies.

  • Zacks 10 days ago

    Can the Rally in Peregrine Pharmaceuticals (PPHM) Shares Continue?

    Peregrine Pharmaceuticals (PPHM) has been on the move lately as the stock has risen by 11.4% in the past four weeks, and it is currently trading well above its 20-Day SMA

  • Zacks 27 days ago

    Peregrine Pharmaceuticals (PPHM) Sees Hammer Chart Pattern: Time to Buy?

    Peregrine Pharmaceuticals, Inc. (PPHM) has been struggling lately, but the selling pressure may be coming to an end soon

  • Capital Cube last month

    ETFs with exposure to Peregrine Pharmaceuticals, Inc. : January 20, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • American City Business Journals last month

    Heat Biologics to reap benefit of new biotech

    Heat Biologics recently announced the appointment of Peregrine Pharmaceuticals (PPHM) alum Dr. Jeff Hutchins as its new chief scientific officer and senior vice president of preclinical development, but the company also stands to benefit from where its former CSO has headed. Former CSO Dr. Taylor Schreiber will not only chair Heat’s scientific advisory board, he’ll also serve as CSO of new biotechnology company Shattuck Labs Inc., according to an announcement from Heat. Shattuck is “developing technology exclusively licensed from Heat,” the Durham-based company said.

  • Capital Cube 2 months ago

    ETFs with exposure to Peregrine Pharmaceuticals, Inc. : January 4, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • 24/7 Wall St. 2 months ago

    Plug Power, Innocoll Drop into Friday’s 52-Week Low Club

    December 30, 2016: Here are four stocks trading with relatively heavy volume among 66 equities making new 52-week lows in Friday’s session. On the NYSE, decliners led advancers by about 3 to 2 and on the ...

  • Capital Cube 2 months ago

    ETFs with exposure to Peregrine Pharmaceuticals, Inc. : December 23, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: Q2, 2017 By the Numbers : December 16, 2016
    Capital Cube 2 months ago

    Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: Q2, 2017 By the Numbers : December 16, 2016

    Categories: Yahoo Finance Get free summary analysis Peregrine Pharmaceuticals, Inc. reports financial results for the quarter ended October 31, 2016. We analyze the earnings along side the following peers of Peregrine Pharmaceuticals, Inc. – Merck & Co., Inc., Pfizer Inc., Eli Lilly and Company, OncoGenex Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Fennec Pharmaceuticals Inc. and Celldex Therapeutics, Inc. (MRK-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents 2 months ago

    Edited Transcript of PPHM earnings conference call or presentation 12-Dec-16 9:30pm GMT

    Q2 2017 Peregrine Pharmaceuticals Inc Earnings Call